These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 20584172)

  • 21. [Selectins in the pathogenesis and diagnosis of early atherosclerotic changes in children and adolescents with risk factors (obesity, hypertension and diabetes)].
    Głowińska B; Urban M; Peczyńska J; Florys B
    Przegl Lek; 2004; 61(9):935-9. PubMed ID: 15803902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variations in the serum concentrations of soluble Fas and soluble Fas ligand in Vietnamese patients infected with hepatitis B virus.
    Song le H; Binh VQ; Duy DN; Bock TC; Kremsner PG; Luty AJ; Mavoungou E
    J Med Virol; 2004 Jun; 73(2):244-9. PubMed ID: 15122799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between metabolic syndrome and platelet responsiveness to leptin in overweight and obese patients.
    Corica F; Corsonello A; Lucchetti M; Malara A; De Domenico D; Cannavò L; Foti S; Valenti A; Ientile R; Saitta A
    Int J Obes (Lond); 2007 May; 31(5):842-9. PubMed ID: 17047640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble Fas (sFas) and soluble Fas ligand (sFas-L) balance in laryngeal carcinoma before and after surgical treatment.
    Pignataro L; Arisi E; Sambataro G; Corsi MM
    J Surg Oncol; 2003 Jun; 83(2):112-5. PubMed ID: 12772205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk-factor clustering and cardiovascular disease risk in hypertensive patients.
    Weycker D; Nichols GA; O'Keeffe-Rosetti M; Edelsberg J; Khan ZM; Kaura S; Oster G
    Am J Hypertens; 2007 Jun; 20(6):599-607. PubMed ID: 17531915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of physical exertion on blood and plasma parameters in healthy subjects and patients with metabolic diseases].
    Mühlfellner G; Mühlfellner O; Neitzert A; Stelbrink U; Zöfel P; Kaffarnik H
    Verh Dtsch Ges Inn Med; 1975; 81():636-9. PubMed ID: 1229570
    [No Abstract]   [Full Text] [Related]  

  • 27. A polymorphism in FAS gene promoter correlated with circulating soluble FAS levels.
    Mahfoudh W; Bel Hadj Jrad B; Romdhane A; Chouchane L
    Int J Immunogenet; 2007 Jun; 34(3):209-12. PubMed ID: 17504511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.
    Bigazzi R; Bianchi S; Batini V; Guzzo D; Campese VM
    Am J Hypertens; 2006 Apr; 19(4):426-31. PubMed ID: 16580581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precursors of atherosclerotic and hypertensive diseases among adolescents in Addis Ababa, Ethiopia.
    Kebede D; Ketsela T
    Bull World Health Organ; 1993; 71(6):787-94. PubMed ID: 8313497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of sFas and sFasL during chemotherapy of lung cancer.
    Naumnik W; Izycki T; Ossolinska M; Chyczewska E
    Exp Oncol; 2007 Jun; 29(2):132-6. PubMed ID: 17704746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome, diabetes and atherosclerosis: influence of gene-environment interaction.
    Andreassi MG
    Mutat Res; 2009 Jul; 667(1-2):35-43. PubMed ID: 19028510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.
    Sacco R; Leuci D; Tortorella C; Fiore G; Marinosci F; Schiraldi O; Antonaci S
    Cytokine; 2000 Jun; 12(6):811-4. PubMed ID: 10843770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum and follicular fluid levels of soluble Fas, soluble Fas ligand and apoptosis of luteinized granulosa cells in PCOS patients undergoing IVF.
    Onalan G; Selam B; Baran Y; Cincik M; Onalan R; Gündüz U; Ural AU; Pabuccu R
    Hum Reprod; 2005 Sep; 20(9):2391-5. PubMed ID: 15932917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
    Tinazzi E; Puccetti A; Gerli R; Rigo A; Migliorini P; Simeoni S; Beri R; Dolcino M; Martinelli N; Corrocher R; Lunardi C
    Int Immunol; 2009 Mar; 21(3):237-43. PubMed ID: 19181929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased soluble FAS suggests delayed apoptosis in familial Mediterranean fever complicated with amyloidosis.
    Kiraz S; Ertenli I; Oztürk MA; Haznedaroglu IC; Calgüneri M; Atalar E; Ozbalkan Z; Kirazli S; Celik I
    J Rheumatol; 2003 Feb; 30(2):313-5. PubMed ID: 12563687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of soluble fas with body mass index in healthy Japanese adults.
    Tamakoshi A; Suzuki K; Lin Y; Ito Y; Yagyu K; Kikuchi S; Watanabe Y; Inaba Y; Tajima K; Nakachi K;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():41-4. PubMed ID: 20553080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Macroangiopathy prophylaxis and diet therapy].
    Honda K; Murase T
    Nihon Rinsho; 1997 Nov; 55 Suppl():53-7. PubMed ID: 9434442
    [No Abstract]   [Full Text] [Related]  

  • 38. The limits of hyperlipemia in metabolic degenerative diseases. The gravimetric value of the total serum lipids separated by chromatography from non-lipid contaminants.
    Andreasik Z
    Pol Arch Med Wewn; 1969; 42(3):299-305. PubMed ID: 5790047
    [No Abstract]   [Full Text] [Related]  

  • 39. [Disorders of lipid metabolism assessed by the changes in the plasma concentrations of apolipoproteins (author's transl)].
    Koga S
    Nihon Naika Gakkai Zasshi; 1980 Oct; 69(10):1239-41. PubMed ID: 7462752
    [No Abstract]   [Full Text] [Related]  

  • 40. [Metabolic disturbances as a cause of diseases in civilized areas. Significance for internal medicine practice].
    Szostak WB
    Pol Arch Med Wewn; 2001; 105 Suppl():193-8. PubMed ID: 12412246
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.